Centene Stock Surges 18%, With A 7-Day Winning Spree
Centene (CNC) – a managed healthcare provider for underinsured and uninsured individuals – hit a 7-day winning streak, with cumulative gains over this period amounting to 18%. The company’s market cap has surged by about $2.8 Bil over the last 7 days and currently stands at $18 Bil.
Is this an opportunity or a trap? There is a near-equal mix of good and bad in CNC stock given its overall Moderate operating performance and financial condition. Taken together with its Very Low valuation, this makes the stock look Attractive (For details, see Buy or Sell CNC).
But here is the interesting part. You are reading about this 18% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
Returns vs S&P 500
- META Stock: The Math Behind The Upside
- TSLA Stock: 4 Impending Events That Could Invalidate the Thesis
- Could This Fuel The Next Surge in Intel Stock
- EPAM Systems Stock: Strong Cash Flow Poised for a Re-Rating?
- Comcast Stock Shares $24 Bil Success With Investors
- 3M Stock Pays Out $24 Bil – Investors Take Note
The following table summarizes the return for CNC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CNC | S&P 500 |
|---|---|---|
| 1D | 0.7% | 0.6% |
| 7D (Current Streak) | 18.1% | 7.6% |
| 1M (21D) | 3.2% | 0.6% |
| 3M (63D) | -18.0% | -1.4% |
| YTD 2026 | -8.7% | -0.3% |
| 2025 | -32.1% | 16.4% |
| 2024 | -18.4% | 23.3% |
| 2023 | -9.5% | 24.2% |
However, big gains can follow sharp reversals – but how has CNC behaved after prior drops? See CNC Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 124 S&P constituents with 3 days or more of consecutive gains and 29 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 50 | 13 |
| 4D | 40 | 13 |
| 5D | 7 | 0 |
| 6D | 1 | 2 |
| 7D or more | 26 | 1 |
| Total >=3 D | 124 | 29 |
Key Financials for Centene (CNC)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $163.1 Bil | $194.8 Bil |
| Operating Income | $3.2 Bil | $-312.0 Mil |
| Net Income | $3.3 Bil | $-6.7 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $49.7 Bil | $49.7 Bil |
| Operating Income | $-211.0 Mil | $-1.2 Bil |
| Net Income | $-6.6 Bil | $-1.1 Bil |
While CNC stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.